Prevnar 13 (Pfizer) Drug Report 2018 - Despite a Slight Drop in US Sales from $3.6Bn in 2016 to $3.4Bn in 2017, Prevnar 13 Maintains a Dominant Hold on the Pneumococcal Vaccine Market - Financialbuzz.com

Prevnar 13 (Pfizer) Drug Report 2018 - Despite a Slight Drop in US Sales from $3.6Bn in 2016 to $3.4Bn in 2017, Prevnar 13 Maintains a Dominant Hold on the Pneumococcal Vaccine Market  Financialbuzz.com

Dublin, June 27, 2019 (GLOBE NEWSWIRE) — The “Prevnar 13” report has been added to ResearchAndMarkets.com's offering. Prevnar 13 (13-valent ...



Comments

Popular posts from this blog

Uveitis Eye Inflammation Causes, Symptoms & Treatment

Outer Ear: Anatomy, Location, and Function - Verywell Health

Chalazion (cyst): Symptoms, pictures, causes, and treatment